Deregulation of the HOXA10 Homeobox Gene in Endometrial Carcinoma: Role in Epithelial-Mesenchymal Transition

H Yoshida, R Broaddus, W Cheng, SS Xie, H Naora - Cancer research, 2006 - AACR
H Yoshida, R Broaddus, W Cheng, SS Xie, H Naora
Cancer research, 2006AACR
Homeobox genes encode transcription factors that control cell differentiation and play
essential roles in developmental patterning. Increasing evidence indicates that many
homeobox genes are aberrantly expressed in cancers, and that their deregulation
significantly contributes to tumor progression. The homeobox gene HOXA10 controls uterine
organogenesis during embryonic development and functional endometrial differentiation in
the adult. We investigated whether HOXA10 expression is deregulated in endometrial …
Abstract
Homeobox genes encode transcription factors that control cell differentiation and play essential roles in developmental patterning. Increasing evidence indicates that many homeobox genes are aberrantly expressed in cancers, and that their deregulation significantly contributes to tumor progression. The homeobox gene HOXA10 controls uterine organogenesis during embryonic development and functional endometrial differentiation in the adult. We investigated whether HOXA10 expression is deregulated in endometrial carcinomas, and how counteracting this aberrant expression modifies tumor behavior. We found that down-regulation of HOXA10 expression in endometrial carcinomas strongly correlates with increased tumor grade and is associated with methylation of the HOXA10 promoter. Enforced expression of HOXA10 in endometrial carcinoma cells inhibited invasive behavior in vitro and tumor dissemination in nude mice. The inhibitory effect of HOXA10 on invasive behavior was attributable at least in part to the ability of HOXA10 to induce expression of the epithelial cell adhesion molecule E-cadherin by down-regulating expression of Snail, a repressor of E-cadherin gene transcription. These findings reveal a novel role for HOXA10 deregulation in the progression of endometrial carcinoma by promoting epithelial-mesenchymal transition. (Cancer Res 2006; 66(2): 889-97)
AACR